Preface |
|
xi | |
Part 1 Foundations |
|
|
1 The Chemical Basis of Life |
|
|
1 | (23) |
|
1.1 What Is Biochemistry? |
|
|
1 | (2) |
|
|
3 | (4) |
|
Cells contain four major types of biomolecules |
|
|
3 | (3) |
|
There are three major kinds of biological polymers |
|
|
6 | (1) |
|
Box 1.A Units Used in Biochemistry |
|
|
7 | (3) |
|
1.3 Energy and Metabolism |
|
|
10 | (4) |
|
Enthalpy and entropy are components of free energy |
|
|
10 | (1) |
|
ΔG is less than zero for a spontaneous process |
|
|
11 | (1) |
|
Life is thermodynamically possible |
|
|
12 | (2) |
|
1.4 The Origin and Evolution of Life |
|
|
14 | (3) |
|
|
14 | (2) |
|
|
16 | (1) |
|
Box 1.13 How Does Evolution Work? |
|
|
17 | (7) |
|
|
24 | (28) |
|
2.1 Water Molecules and Hydrogen Bonds |
|
|
24 | (4) |
|
Hydrogen bonds are one type of electrostatic force |
|
|
26 | (2) |
|
Box 2.A Why Do Some Drugs Contain Fluorine? |
|
|
28 | (1) |
|
Water dissolves many compounds |
|
|
28 | (1) |
|
2.2 The Hydrophobic Effect |
|
|
29 | (3) |
|
Amphiphilic molecules experience both hydrophilic interactions and the hydrophobic effect |
|
|
31 | (1) |
|
The hydrophobic core of a lipid bilayer is a barrier to diffusion |
|
|
31 | (1) |
|
Box 2.B Sweat, Exercise, and Sports Drinks |
|
|
32 | (1) |
|
|
33 | (2) |
|
[ H+] and [ OH-] are inversely related |
|
|
33 | (1) |
|
The pH of a solution can be altered |
|
|
34 | (1) |
|
Box 2.0 Atmospheric CO2 and Ocean Acidification |
|
|
35 | (5) |
|
A pK value describes an acid's tendency to ionize |
|
|
36 | (1) |
|
The pH of a solution of acid is related to the pK |
|
|
37 | (3) |
|
2.4 Tools and Techniques: Buffers |
|
|
40 | (2) |
|
2.5 Clinical Connection: Acid-Base Balance in Humans |
|
|
42 | (10) |
Part 2 Molecular Structure and Function |
|
|
|
52 | (33) |
|
|
52 | (4) |
|
Nucleic acids are polymers of nucleotides |
|
|
53 | (1) |
|
Some nucleotides have other functions |
|
|
54 | (2) |
|
3.2 Nucleic Acid Structure |
|
|
56 | (5) |
|
|
56 | (3) |
|
|
59 | (1) |
|
Nucleic acids can be denatured and renatured |
|
|
59 | (2) |
|
|
61 | (3) |
|
|
62 | (1) |
|
A mutated gene can cause disease |
|
|
63 | (1) |
|
|
64 | (4) |
|
Gene number is roughly correlated with organismal complexity |
|
|
65 | (1) |
|
Genes are identified by comparing sequences |
|
|
66 | (1) |
|
Genomic data reveal biological functions |
|
|
67 | (1) |
|
3.5 Tools and Techniques: Manipulating DNA |
|
|
68 | (4) |
|
Cutting and pasting generates recombinant DNA |
|
|
69 | (2) |
|
The polymerase chain reaction amplifies DNA |
|
|
71 | (1) |
|
Box 3.A Genetically Modified Organisms |
|
|
72 | (2) |
|
Box 3.B DNA Fingerprinting |
|
|
74 | (11) |
|
DNA sequencing uses DNA polymerase to make a complementary strand |
|
|
74 | (2) |
|
|
76 | (9) |
|
|
85 | (34) |
|
4.1 Amino Acids, the Building Blocks of Proteins |
|
|
86 | (2) |
|
The 20 amino acids have different chemical properties |
|
|
87 | (1) |
|
Box 4.A Does Chirality Matter? |
|
|
88 | (2) |
|
Box 4.B Monosodium Glutamate |
|
|
90 | (4) |
|
Peptide bonds link amino acids in proteins |
|
|
90 | (3) |
|
The amino acid sequence is the first level of protein structure |
|
|
93 | (1) |
|
4.2 Secondary Structure: The Conformation of the Peptide Group |
|
|
94 | (3) |
|
The a helix exhibits a twisted backbone conformation |
|
|
95 | (1) |
|
The p sheet contains multiple polypeptide strands |
|
|
95 | (1) |
|
Proteins also contain irregular secondary structure |
|
|
96 | (1) |
|
4.3 Tertiary Structure and Protein Stability |
|
|
97 | (7) |
|
Proteins have hydrophobic cores |
|
|
98 | (1) |
|
Protein structures are stabilized mainly by the hydrophobic effect |
|
|
99 | (1) |
|
Other interactions help stabilize proteins |
|
|
100 | (1) |
|
Protein folding begins with the formation of secondary structures |
|
|
101 | (1) |
|
Some proteins have more than one conformation |
|
|
102 | (2) |
|
|
104 | (1) |
|
4.5 Clinical Connection: Protein Misfolding and Disease |
|
|
105 | (2) |
|
4.6 Tools and Techniques: Analyzing Protein Structure |
|
|
107 | (3) |
|
Chromatography takes advantage of a polypeptide's unique properties |
|
|
107 | (2) |
|
Mass spectrometry reveals amino acid sequences |
|
|
109 | (1) |
|
Protein structures are determined by X-ray crystallography, electron crystallography, and NMR spectroscopy |
|
|
110 | (1) |
|
Box 4.0 Mass Spectrometry Applications |
|
|
110 | (9) |
|
|
119 | (35) |
|
5.1 Myoglobin and Hemoglobin: Oxygen-Binding Proteins |
|
|
120 | (4) |
|
Oxygen binding to myoglobin depends on the oxygen concentration |
|
|
120 | (1) |
|
Myoglobin and hemoglobin are related by evolution |
|
|
121 | (2) |
|
Oxygen binds cooperatively to hemoglobin |
|
|
123 | (1) |
|
A conformational shift explains hemoglobin's cooperative behavior |
|
|
124 | (1) |
|
Box 5.A Carbon Monoxide Poisoning |
|
|
124 | (3) |
|
H+ ions and bisphosphoglycerate regulate oxygen binding to hemoglobin in vivo |
|
|
126 | (1) |
|
5.2 Clinical Connection: Hemoglobin Variants |
|
|
127 | (3) |
|
|
130 | (7) |
|
Actin filaments are most abundant |
|
|
130 | (1) |
|
Actin filaments continuously extend and retract |
|
|
131 | (1) |
|
Tubulin forms hollow microtubules |
|
|
132 | (2) |
|
Some drugs affect microtubules |
|
|
134 | (1) |
|
Keratin is an intermediate filament |
|
|
135 | (1) |
|
Collagen is a triple helix |
|
|
136 | (1) |
|
Box 5.B Vitamin C Deficiency Causes Scurvy |
|
|
137 | (2) |
|
Collagen molecules are covalently cross-linked |
|
|
139 | (1) |
|
Box 5.0 Bone and Collagen Defects |
|
|
139 | (2) |
|
|
141 | (3) |
|
Myosin has two heads and a long tail |
|
|
141 | (1) |
|
Myosin operates through a lever mechanism |
|
|
142 | (1) |
|
Kinesin is a microtubule-associated motor protein |
|
|
143 | (1) |
|
Box 5.D Myosin Mutations and Deafness |
|
|
144 | (10) |
|
Kinesin is a processive motor |
|
|
146 | (8) |
|
|
154 | (29) |
|
|
154 | (4) |
|
Enzymes are usually named after the reaction they catalyze |
|
|
157 | (1) |
|
6.2 Chemical Catalytic Mechanisms |
|
|
158 | (4) |
|
A catalyst provides a reaction pathway with a lower activation energy barrier |
|
|
159 | (1) |
|
Enzymes use chemical catalytic mechanisms |
|
|
160 | (2) |
|
Box 6.A Depicting Reaction Mechanisms |
|
|
162 | (4) |
|
The catalytic triad of chymotrypsin promotes peptide bond hydrolysis |
|
|
164 | (2) |
|
6.3 Unique Properties of Enzyme Catalysts |
|
|
166 | (3) |
|
Enzymes stabilize the transition state |
|
|
166 | (2) |
|
Efficient catalysis depends on proximity and orientation effects |
|
|
168 | (1) |
|
The active-site microenvironment promotes catalysis |
|
|
168 | (1) |
|
6.4 Chymotrypsin in Context |
|
|
169 | (4) |
|
Not all serine proteases are related by evolution |
|
|
170 | (1) |
|
Enzymes with similar mechanisms exhibit different substrate specificity |
|
|
170 | (1) |
|
Chymotrypsin is activated by proteolysis |
|
|
171 | (1) |
|
Protease inhibitors limit protease activity |
|
|
172 | (1) |
|
6.5 Clinical Connection: Blood Coagulation |
|
|
173 | (10) |
|
7 Enzyme Kinetics and Inhibition |
|
|
183 | (32) |
|
7.1 Introduction to Enzyme Kinetics |
|
|
183 | (3) |
|
7.2 Derivation and Meaning of the Michaelis-Menten Equation |
|
|
186 | (8) |
|
Rate equations describe chemical processes |
|
|
186 | (1) |
|
The Michaelis-Menten equation is a rate equation for an enzyme-catalyzed reaction |
|
|
187 | (2) |
|
KM is the substrate concentration at which velocity is half-maximal |
|
|
189 | (1) |
|
The catalytic constant describes how quickly an enzyme can act |
|
|
190 | (1) |
|
kcat/KM indicates catalytic efficiency |
|
|
190 | (1) |
|
KM and Vmax are experimentally determined |
|
|
191 | (1) |
|
Not all enzymes fit the simple Michaelis-Menten model |
|
|
192 | (2) |
|
|
194 | (4) |
|
Some inhibitors act irreversibly |
|
|
195 | (1) |
|
Competitive inhibition is the most common form of reversible enzyme inhibition |
|
|
195 | (2) |
|
Transition state analogs inhibit enzymes |
|
|
197 | (1) |
|
Box 7.A Inhibitors of HIV Protease |
|
|
198 | (6) |
|
Other types of inhibitors affect Vmax |
|
|
199 | (1) |
|
Allosteric enzyme regulation includes inhibition and activation |
|
|
200 | (3) |
|
Several factors may influence enzyme activity |
|
|
203 | (1) |
|
7.4 Clinical Connection: Drug Development |
|
|
204 | (11) |
|
|
215 | (20) |
|
|
215 | (1) |
|
Fatty acids contain long hydrocarbon chains |
|
|
216 | (1) |
|
Box 8.A Omega-3 Fatty Acids |
|
|
216 | (5) |
|
Some lipids contain polar head groups |
|
|
217 | (2) |
|
Lipids perform a variety of physiological functions |
|
|
219 | (2) |
|
Box 8.B The Lipid Vitamins A, D, E, and K |
|
|
221 | (1) |
|
|
222 | (3) |
|
The bilayer is a fluid structure |
|
|
223 | (1) |
|
Natural bilayers are asymmetric |
|
|
224 | (1) |
|
|
225 | (3) |
|
Integral membrane proteins span the bilayer |
|
|
225 | (1) |
|
An a helix can cross the bilayer |
|
|
226 | (1) |
|
A transmembrane β sheet forms a barrel |
|
|
226 | (1) |
|
Lipid-linked proteins are anchored in the membrane |
|
|
227 | (1) |
|
8.4 The Fluid Mosaic Model |
|
|
228 | (7) |
|
Membrane glycoproteins face the cell exterior |
|
|
229 | (6) |
|
|
235 | (25) |
|
9.1 The Thermodynamics of Membrane Transport |
|
|
235 | (5) |
|
Ion movements alter membrane potential |
|
|
237 | (1) |
|
Membrane proteins mediate transmembrane ion movement |
|
|
237 | (3) |
|
|
240 | (2) |
|
Porins are β barrel proteins |
|
|
240 | (1) |
|
Ion channels are highly selective |
|
|
241 | (1) |
|
|
242 | (3) |
|
Gated channels undergo conformational changes |
|
|
242 | (1) |
|
Aquaporins are water-specific pores |
|
|
243 | (1) |
|
Some transport proteins alternate between conformations |
|
|
244 | (1) |
|
|
245 | (3) |
|
The Na,K-ATPase changes conformation as it pumps ions across the membrane |
|
|
246 | (1) |
|
ABC transporters mediate drug resistance |
|
|
247 | (1) |
|
Secondary active transport exploits existing gradients |
|
|
247 | (1) |
|
|
248 | (2) |
|
Box 9.B Antidepressants Block Serotonin Transport |
|
|
250 | (3) |
|
SNARES link vesicle and plasma membranes |
|
|
251 | (1) |
|
Endocytosis is the reverse of exocytosis |
|
|
252 | (1) |
|
|
253 | (7) |
|
|
260 | (23) |
|
10.1 General Features of Signaling Pathways |
|
|
260 | (2) |
|
A ligand binds to a receptor with a characteristic affinity |
|
|
261 | (1) |
|
Box 10.A Bacterial Quorum Sensing |
|
|
262 | (3) |
|
Most signaling occurs through two types of receptors |
|
|
263 | (1) |
|
The effects of signaling are limited |
|
|
264 | (1) |
|
10.2 G Protein Signaling Pathways |
|
|
265 | (5) |
|
G protein-coupled receptors include seven transmembrane helices |
|
|
265 | (1) |
|
The receptor activates a G protein |
|
|
265 | (1) |
|
Adenylate cyclase generates the second messenger cyclic AMP |
|
|
266 | (1) |
|
Cyclic AMP activates protein kinase A |
|
|
267 | (1) |
|
Signaling pathways are also switched off |
|
|
267 | (2) |
|
The phosphoinositide signaling pathway generates two second messengers |
|
|
269 | (1) |
|
Calmodulin mediates some Ca2+ signals |
|
|
270 | (1) |
|
10.3 Receptor Tyrosine Kinases |
|
|
270 | (3) |
|
The insulin receptor dimer binds one insulin |
|
|
271 | (1) |
|
The receptor undergoes autophosphorylation |
|
|
271 | (2) |
|
Box 10.13 Cell Signaling and Cancer |
|
|
273 | (1) |
|
10.4 Lipid Hormone Signaling |
|
|
274 | (2) |
|
Eicosanoids are short-range signals |
|
|
275 | (1) |
|
Box 10.0 Aspirin and Other Inhibitors of Cyclooxygenase |
|
|
276 | (7) |
|
|
283 | (18) |
|
|
283 | (4) |
|
Most carbohydrates are chiral compounds |
|
|
284 | (1) |
|
Cyclization generates a and p anomers |
|
|
285 | (1) |
|
Monosaccharides can be derivatized in many different ways |
|
|
286 | (1) |
|
|
287 | (3) |
|
Lactose and sucrose are the most common disaccharides |
|
|
288 | (1) |
|
Starch and glycogen are fuel-storage molecules |
|
|
288 | (1) |
|
Cellulose and chitin provide structural support |
|
|
289 | (1) |
|
Box 11.A Cellulosic Biofuel |
|
|
290 | (1) |
|
Bacterial polysaccharides form a biofilm |
|
|
291 | (1) |
|
|
291 | (2) |
|
Oligosaccharides are N-linked or O-linked |
|
|
292 | (1) |
|
Oligosaccharide groups are biological markers |
|
|
293 | (1) |
|
Box 11.B The ABO Blood Group System |
|
|
293 | (8) |
|
Proteoglycans contain long glycosaminoglycan chains |
|
|
294 | (1) |
|
Bacterial cell walls are made of peptidoglycan |
|
|
295 | (6) |
Part 3 Metabolism |
|
|
12 Metabolism and Bioenergetics |
|
|
301 | (28) |
|
|
301 | (2) |
|
Cells take up the products of digestion |
|
|
302 | (1) |
|
Box 12.A Dietary Guidelines |
|
|
303 | (3) |
|
Monomers are stored as polymers |
|
|
304 | (1) |
|
Fuels are mobilized as needed |
|
|
304 | (2) |
|
|
306 | (5) |
|
Some major metabolic pathways share a few common intermediates |
|
|
307 | (1) |
|
Many metabolic pathways include oxidation-reduction reactions |
|
|
308 | (2) |
|
Metabolic pathways are complex |
|
|
310 | (1) |
|
Box 12.B The Transcriptome, the Proteome, and the Metabolome |
|
|
311 | (3) |
|
Human metabolism depends on vitamins |
|
|
312 | (2) |
|
12.3 Free Energy Changes in Metabolic Reactions |
|
|
314 | (6) |
|
The free energy change depends on reactant concentrations |
|
|
314 | (2) |
|
Unfavorable reactions are coupled to favorable reactions |
|
|
316 | (2) |
|
Free energy can take different forms |
|
|
318 | (2) |
|
Box 12.0 Powering Human Muscles |
|
|
320 | (9) |
|
Regulation occurs at the steps with the largest free energy changes |
|
|
321 | (8) |
|
|
329 | (33) |
|
|
330 | (10) |
|
Reactions 1-5 are the energy-investment phase of glycolysis |
|
|
330 | (6) |
|
Reactions 6-10 are the energy-payoff phase of glycolysis |
|
|
336 | (4) |
|
Box 13.A Catabolism of Other Sugars |
|
|
340 | (2) |
|
Pyruvate is converted to other substances |
|
|
341 | (1) |
|
Box 13.B Alcohol Metabolism |
|
|
342 | (2) |
|
|
344 | (3) |
|
Four gluconeogenic enzymes plus some glycolytic enzymes convert pyruvate to glucose |
|
|
345 | (1) |
|
Gluconeogenesis is regulated at the fructose bisphosphatase step |
|
|
346 | (1) |
|
13.3 Glycogen Synthesis and Degradation |
|
|
347 | (3) |
|
Glycogen synthesis consumes the free energy of UTP |
|
|
348 | (1) |
|
Glycogen phosphorylase catalyzes glycogenolysis |
|
|
349 | (1) |
|
13.4 The Pentose Phosphate Pathway |
|
|
350 | (3) |
|
The oxidative reactions of the pentose phosphate pathway produce NADPH |
|
|
350 | (1) |
|
Isomerization and interconversion reactions generate a variety of monosaccharides |
|
|
351 | (1) |
|
A summary of glucose metabolism |
|
|
352 | (1) |
|
13.5 Clinical Connection: Disorders of Carbohydrate Metabolism |
|
|
353 | (9) |
|
Glycogen storage diseases affect liver and muscle |
|
|
354 | (8) |
|
|
362 | (23) |
|
14.1 The Pyruvate Dehydrogenase Reaction |
|
|
362 | (3) |
|
The pyruvate dehydrogenase complex contains multiple copies of three different enzymes |
|
|
363 | (1) |
|
Pyruvate dehydrogenase converts pyruvate to acetyl-CoA |
|
|
363 | (2) |
|
14.2 The Eight Reactions of the Citric Acid Cycle |
|
|
365 | (7) |
|
1 Citrate synthase adds an acetyl group to oxaloacetate |
|
|
366 | (2) |
|
2 Aconitase isomerizes citrate to isocitrate |
|
|
368 | (1) |
|
3 Isocitrate dehydrogenase releases the first CO2 |
|
|
369 | (1) |
|
4 α-Ketoglutarate dehydrogenase releases the second CO2 |
|
|
369 | (1) |
|
5 Succinyl-CoA synthetase catalyzes substrate-level phosphorylation |
|
|
370 | (1) |
|
6 Succinate dehydrogenase generates ubiquinol |
|
|
370 | (1) |
|
7 Fumarase catalyzes a hydration reaction |
|
|
371 | (1) |
|
8 Malate dehydrogenase regenerates oxaloacetate |
|
|
371 | (1) |
|
14.3 Thermodynamics of the Citric Acid Cycle |
|
|
372 | (1) |
|
The citric acid cycle is an energy-generating catalytic cycle |
|
|
372 | (1) |
|
The citric acid cycle is regulated at three steps |
|
|
372 | (1) |
|
The citric acid cycle probably evolved as a synthetic pathway |
|
|
373 | (1) |
|
Box 14.A Mutations in Citric Acid Cycle Enzymes |
|
|
373 | (2) |
|
14.4 Anabolic and Catabolic Functions of the Citric Acid Cycle |
|
|
375 | (2) |
|
Citric acid cycle intermediates are precursors of other molecules |
|
|
375 | (1) |
|
Anaplerotic reactions replenish citric acid cycle intermediates |
|
|
376 | (1) |
|
Box 14.B The Glyoxylate Pathway |
|
|
377 | (8) |
|
15 Oxidative Phosphorylation |
|
|
385 | (26) |
|
15.1 The Thermodynamics of Oxidation-Reduction Reactions |
|
|
385 | (5) |
|
Reduction potential indicates a substance's tendency to accept electrons |
|
|
386 | (2) |
|
The free energy change can be calculated from the change in reduction potential |
|
|
388 | (2) |
|
15.2 Mitochondrial Electron Transport |
|
|
390 | (8) |
|
Mitochondrial membranes define two compartments |
|
|
390 | (2) |
|
Complex I transfers electrons from NADH to ubiquinone |
|
|
392 | (2) |
|
Other oxidation reactions contribute to the ubiquinol pool |
|
|
394 | (1) |
|
Complex III transfers electrons from ubiquinol to cytochrome c |
|
|
394 | (3) |
|
Complex IV oxidizes cytochrome c and reduces O2 |
|
|
397 | (1) |
|
Box 15.A Free Radicals and Aging |
|
|
398 | (1) |
|
|
399 | (2) |
|
Chemiosmosis links electron transport and oxidative phosphorylation |
|
|
400 | (1) |
|
The proton gradient is an electrochemical gradient |
|
|
400 | (1) |
|
|
401 | (3) |
|
ATP synthase rotates as it translocates protons |
|
|
401 | (2) |
|
The binding change mechanism explains how ATP is made |
|
|
403 | (1) |
|
The P:O ratio describes the stoichiometry of oxidative phosphorylation |
|
|
403 | (1) |
|
Box 15.B Uncoupling Agents Prevent ATP Synthesis |
|
|
404 | (7) |
|
The rate of oxidative phosphorylation depends on the rate of fuel catabolism |
|
|
404 | (7) |
|
|
411 | (21) |
|
16.1 Chloroplasts and Solar Energy |
|
|
411 | (4) |
|
Pigments absorb light of different wavelengths |
|
|
412 | (2) |
|
Light-harvesting complexes transfer energy to the reaction center |
|
|
414 | (1) |
|
|
415 | (7) |
|
Photosystem II is a light-activated oxidation-reduction enzyme |
|
|
416 | (1) |
|
The oxygen-evolving complex of Photosystem II oxidizes water |
|
|
417 | (1) |
|
Cytochrome b6f links Photosystems I and II |
|
|
418 | (1) |
|
A second photooxidation occurs at Photosystem I |
|
|
419 | (2) |
|
Chemiosmosis provides the free energy for ATP synthesis |
|
|
421 | (1) |
|
|
422 | (2) |
|
Rubisco catalyzes CO2 fixation |
|
|
422 | (2) |
|
|
424 | (8) |
|
The Calvin cycle rearranges sugar molecules |
|
|
424 | (2) |
|
The availability of light regulates carbon fixation |
|
|
426 | (1) |
|
Calvin cycle products are used to synthesize sucrose and starch |
|
|
426 | (6) |
|
|
432 | (32) |
|
|
432 | (3) |
|
17.2 Fatty Acid Oxidation |
|
|
435 | (8) |
|
Fatty acids are activated before they are degraded |
|
|
435 | (1) |
|
Each round of β oxidation has four reactions |
|
|
436 | (3) |
|
Degradation of unsaturated fatty acids requires isomerization and reduction |
|
|
439 | (1) |
|
Oxidation of odd-chain fatty acids yields propionyl-CoA |
|
|
440 | (2) |
|
Some fatty acid oxidation occurs in peroxisomes |
|
|
442 | (1) |
|
17.3 Fatty Acid Synthesis |
|
|
443 | (5) |
|
Acetyl-CoA carboxylase catalyzes the first step of fatty acid synthesis |
|
|
444 | (1) |
|
Fatty acid synthase catalyzes seven reactions |
|
|
445 | (2) |
|
Other enzymes elongate and desaturate newly synthesized fatty acids |
|
|
447 | (1) |
|
Box 17.A Fats, Diet, and Heart Disease |
|
|
448 | (2) |
|
Fatty acid synthesis can be activated and inhibited |
|
|
449 | (1) |
|
Box 17.B Inhibitors of Fatty Acid Synthesis |
|
|
450 | (2) |
|
Acetyl-CoA can be converted to ketone bodies |
|
|
450 | (2) |
|
17.4 Synthesis of Other Lipids |
|
|
452 | (12) |
|
Triacylglycerols and phospholipids are built from acyl-CoA groups |
|
|
452 | (2) |
|
Cholesterol synthesis begins with acetyl-CoA |
|
|
454 | (3) |
|
A summary of lipid metabolism |
|
|
457 | (7) |
|
|
464 | (33) |
|
18.1 Nitrogen Fixation and Assimilation |
|
|
464 | (5) |
|
Nitrogenase converts N2 to NH3 |
|
|
465 | (1) |
|
Ammonia is assimilated by glutamine synthetase and glutamate synthase |
|
|
466 | (1) |
|
Transamination moves amino groups between compounds |
|
|
467 | (2) |
|
Box 18.A Transaminases in the Clinic |
|
|
469 | (1) |
|
18.2 Amino Acid Biosynthesis |
|
|
469 | (4) |
|
Several amino acids are easily synthesized from common metabolites |
|
|
470 | (1) |
|
Amino acids with sulfur, branched chains, or aromatic groups are more difficult to synthesize |
|
|
471 | (2) |
|
Box 18.B Glyphosate, the Most Popular Herbicide |
|
|
473 | (3) |
|
Amino acids are the precursors of some signaling molecules |
|
|
475 | (1) |
|
|
476 | (1) |
|
18.3 Amino Acid Catabolism |
|
|
476 | (4) |
|
Amino acids are glucogenic, ketogenic, or both |
|
|
477 | (3) |
|
Box 18.D Diseases of Amino Acid Metabolism |
|
|
480 | (1) |
|
18.4 Nitrogen Disposal: The Urea Cycle |
|
|
480 | (5) |
|
Glutamate supplies nitrogen to the urea cycle |
|
|
481 | (1) |
|
The urea cycle consists of four reactions |
|
|
482 | (3) |
|
18.5 Nucleotide Metabolism |
|
|
485 | (12) |
|
Purine nucleotide synthesis yields IMP and then AMP and GMP |
|
|
485 | (1) |
|
Pyrimidine nucleotide synthesis yields UTP and CTP |
|
|
486 | (1) |
|
Ribonucleotide reductase converts ribonucleotides to deoxyribonucleotides |
|
|
487 | (1) |
|
Thymidine nucleotides are produced by methylation |
|
|
488 | (1) |
|
Nucleotide degradation produces uric acid or amino acids |
|
|
489 | (8) |
|
19 Regulation of Mammalian Fuel Metabolism |
|
|
497 | (22) |
|
19.1 Integration of Fuel Metabolism |
|
|
498 | (2) |
|
Organs are specialized for different functions |
|
|
498 | (1) |
|
Metabolites travel between organs |
|
|
499 | (1) |
|
Box 19.A The Intestinal Microbiome Contributes to Metabolism |
|
|
500 | (1) |
|
19.2 Hormonal Control of Fuel Metabolism |
|
|
501 | (6) |
|
Insulin is released in response to glucose |
|
|
502 | (1) |
|
Insulin promotes fuel use and storage |
|
|
503 | (1) |
|
Glucagon and epinephrine trigger fuel mobilization |
|
|
504 | (1) |
|
Additional hormones influence fuel metabolism |
|
|
505 | (1) |
|
AMP-dependent protein kinase acts as a fuel sensor |
|
|
506 | (1) |
|
19.3 Disorders of Fuel Metabolism |
|
|
507 | (1) |
|
The body generates glucose and ketone bodies during starvation |
|
|
507 | (1) |
|
Box 19.B Marasmus and Kwashiorkor |
|
|
507 | (4) |
|
Obesity has multiple causes |
|
|
508 | (1) |
|
Diabetes is characterized by hyperglycemia |
|
|
509 | (2) |
|
The metabolic syndrome links obesity and diabetes |
|
|
511 | (1) |
|
19.4 Clinical Connection: Cancer Metabolism |
|
|
511 | (8) |
|
Aerobic glycolysis supports biosynthesis |
|
|
512 | (1) |
|
Cancer cells consume large amounts of glutamine |
|
|
512 | (7) |
Part 4 Genetic Information |
|
|
20 DNA Replication and Repair |
|
|
519 | (32) |
|
20.1 The DNA Replication Machinery |
|
|
519 | (9) |
|
Replication occurs in factories |
|
|
520 | (1) |
|
Helicases convert double-stranded DNA to single-stranded DNA |
|
|
521 | (1) |
|
DNA polymerase faces two problems |
|
|
522 | (1) |
|
DNA polymerases share a common structure and mechanism |
|
|
523 | (2) |
|
DNA polymerase proofreads newly synthesized DNA |
|
|
525 | (1) |
|
An RNase and a ligase are required to complete the lagging strand |
|
|
525 | (3) |
|
|
528 | (2) |
|
Telomerase extends chromosomes |
|
|
529 | (1) |
|
Box 20.A HIV Reverse Transcriptase |
|
|
530 | (1) |
|
Is telomerase activity linked to cell immortality? |
|
|
531 | (1) |
|
20.3 DNA Damage and Repair |
|
|
531 | (7) |
|
DNA damage is unavoidable |
|
|
531 | (2) |
|
Repair enzymes restore some types of damaged DNA |
|
|
533 | (1) |
|
Base excision repair corrects the most frequent DNA lesions |
|
|
533 | (2) |
|
Nucleotide excision repair targets the second most common form of DNA damage |
|
|
535 | (1) |
|
Double-strand breaks can be repaired by joining the ends |
|
|
535 | (1) |
|
Recombination also restores broken DNA molecules |
|
|
536 | (2) |
|
20.4 Clinical Connection: Cancer as a Genetic Disease |
|
|
538 | (2) |
|
Tumor growth depends on multiple events |
|
|
538 | (1) |
|
DNA repair pathways are closely linked to cancer |
|
|
539 | (1) |
|
|
540 | (11) |
|
DNA is negatively supercoiled |
|
|
541 | (1) |
|
Topoisomerases alter DNA supercoiling |
|
|
541 | (2) |
|
Eukaryotic DNA is packaged in nucleosomes |
|
|
543 | (8) |
|
|
551 | (29) |
|
21.1 Initiating Transcription |
|
|
552 | (6) |
|
|
552 | (1) |
|
DNA packaging affects transcription |
|
|
553 | (2) |
|
DNA also undergoes covalent modification |
|
|
555 | (1) |
|
Transcription begins at promoters |
|
|
555 | (2) |
|
Transcription factors recognize eukaryotic promoters |
|
|
557 | (1) |
|
Enhancers and silencers act at a distance from the promoter |
|
|
558 | (1) |
|
Box 21.A DNA-Binding Proteins |
|
|
558 | (4) |
|
Prokaryotic operons allow coordinated gene expression |
|
|
560 | (2) |
|
|
562 | (5) |
|
RNA polymerases have a common structure and mechanism |
|
|
562 | (2) |
|
RNA polymerase is a processive enzyme |
|
|
564 | (1) |
|
Transcription elongation requires a conformational change in RNA polymerase |
|
|
564 | (1) |
|
Transcription is terminated in several ways |
|
|
565 | (2) |
|
|
567 | (13) |
|
Eukaryotic mRNAs receive a 5' cap and a 3' poly(A) tail |
|
|
567 | (1) |
|
Splicing removes introns from eukaryotic RNA |
|
|
567 | (2) |
|
mRNA turnover and RNA interference limit gene expression |
|
|
569 | (3) |
|
rRNA and tRNA processing includes the addition, deletion, and modification of nucleotides |
|
|
572 | (1) |
|
RNAs have extensive secondary structure |
|
|
573 | (7) |
|
|
580 | |
|
22.1 tRNA and the Genetic Code |
|
|
580 | (5) |
|
The genetic code is redundant |
|
|
581 | (1) |
|
tRNAs have a common structure |
|
|
581 | (1) |
|
tRNA aminoacylation consumes ATP |
|
|
582 | (2) |
|
Some synthetases have proofreading activity |
|
|
584 | (1) |
|
tRNA anticodons pair with mRNA codons |
|
|
584 | (1) |
|
Box 22.A The Genetic Code Expanded |
|
|
585 | (1) |
|
|
586 | (3) |
|
The ribosome is mostly RNA |
|
|
586 | (1) |
|
Three tRNAs bind to the ribosome |
|
|
587 | (2) |
|
|
589 | (5) |
|
Initiation requires an initiator tRNA |
|
|
589 | (1) |
|
The appropriate tRNAs are delivered to the ribosome during elongation |
|
|
590 | (3) |
|
The peptidyl transferase active site catalyzes peptide bond formation |
|
|
593 | (1) |
|
Box 22.B Antibiotic Inhibitors of Protein Synthesis |
|
|
594 | (3) |
|
Release factors mediate translation termination |
|
|
595 | (1) |
|
Translation is efficient in vivo |
|
|
596 | (1) |
|
22.4 Post-Translational Events |
|
|
597 | |
|
Chaperones promote protein folding |
|
|
597 | (2) |
|
The signal recognition particle targets some proteins for membrane translocation |
|
|
599 | (1) |
|
Many proteins undergo covalent modification |
|
|
600 | |
Glossary |
|
G-1 | |
Odd-Numbered Solutions |
|
S-1 | |
Index |
|
1-1 | |